S(-)-Cyanopindolol hemifumarate

5-HT1A/1B serotonin receptor antagonist; β3-adrenoceptor antagonist

S(–)-Cyanopindolol hemifumarate is a pharmacological research compound used primarily as a high-affinity ligand for certain G-protein-coupled receptors (GPCRs). It is not used clinically, but has been important in basic receptor characterization and pharmacology studies.

Primary Functional Activities

1. β-Adrenergic Receptor Antagonist / Ligand
   • It binds with high affinity to β-adrenergic receptors (β₁ and β₂ subtypes) found in cardiovascular and other tissues.
   • Functionally it blocks (antagonizes) activation by endogenous agonists such as adrenaline/noradrenaline, preventing downstream signalling (e.g., cAMP production via Gs proteins).

2. Serotonin (5-HT) Receptor Antagonist
   • It is also a potent antagonist at serotonin receptor subtypes 5-HT₁A and 5-HT₁B — receptors involved in regulating serotonin release and neuronal signalling.
   • Blocking these autoreceptors can increase synaptic serotonin by reducing inhibitory feedback, a mechanism explored in neuroscience research.

Pharmacological Features

• Antagonism vs Partial Agonism: While mainly categorized as an antagonist, in some experimental systems S(–)-Cyanopindolol shows weak partial agonist or inverse agonist behavior depending on receptor subtype, expression level, and system context.

• High Binding Affinity: Its strong affinity for β-adrenoceptors has made it useful as a radioligand (when labeled with isotopes like ¹²⁵I) to quantify receptor density and subtype distribution in tissues.

• Structural Research Tool: Crystallographic studies of the β-adrenergic receptor bound to cyanopindolol have helped elucidate how antagonists stabilize inactive receptor conformations and identify key binding interactions.

Receptor Interaction Summary